In randomized double-blind clinical trials, a new vaccine was tested on infants who were randomly divided into two groups. The experimental group received the new vaccine, while the control group received a different vaccine. After the second dose, 126 out of 658 subjects in the experimental group (group 1) experienced fever as a side effect. In the control group (group 2), 83 out of 539 subjects experienced fever as a side effect. Does the evidence suggest that a higher proportion of subjects in group 1 experienced fever as a side effect compared to subjects in group 2 at the 0.10 level of significance?